News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
Pfizer (PFE)'s $11 Billion Buyback Dims Prospects Of AstraZeneca PLC (AZN) Bid 10/24/2014
Amgen (AMGN) To Webcast 2014 Business Review Meeting On October 28 10/24/2014
PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change And Launches New Corporate Website 10/24/2014
Zafgen (ZFGN) To Ring The Nasdaq Stock Market Closing Bell 10/24/2014
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $6 Million 10/24/2014
AptarGroup Declares Quarterly Dividend 10/24/2014
Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan 10/23/2014
Celator Pharmaceuticals, Inc. Announces Pricing Of A $12.9 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock 10/23/2014
Notice Of Extraordinary General Meeting Of Medivir AB (MVRBF) (Publ) 10/23/2014
TetraPhase PharmaceuticalsAnnounces Closing Of Public Offering Of Common Stock 10/23/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen 10/23/2014
Celgene (CELG) Beats The Street Again On Earnings And Analysts Couldn’t Be Happier 10/23/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program 10/22/2014
Bioren, Inc. Announces Additional Orders For $1.7 Million 10/22/2014
Clovis Oncology (CLVS) To Announce Third Quarter 2014 Financial Results And Host Webcast Conference Call On November 6 10/22/2014
Flexion Therapeutics (FLXN) To Ring The Nasdaq Stock Market Opening Bel 10/22/2014
Amgen (AMGN) Statement Regarding Third Point Investment 10/22/2014
Esperion Therapeutics, Inc. (ESPR) Announces Closing Of Follow-On Public Offering And Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock 10/22/2014
Hold Your Horses On Splicing Amgen (AMGN), Say Citi Analysts 10/22/2014
ISI Group: AbbVie (ABBV)’s Dividend, Repurchasing Attempt Could Mean More Debt 10/21/2014
Celgene (CELG)’s New Crohn’s Disease Drug Impressing Analysts 10/21/2014
SWK Holdings Corporation Establishes Record Date For Rights Offering 10/21/2014
Ablynx (ABLYF) Announces Warrant Exercise 10/21/2014
Aurinia (ISA.TO) To Host Lupus Opinion Leader Meeting And Webcast On October 23 In New York City 10/21/2014
Aptose Biosciences Announces Approval For Listing On The NASDAQ Capital Market Shares To Begin Trading Under The Symbol APTO 10/21/2014
AbbVie (ABBV) Announces New $5 Billion Stock Repurchase Program And Increases Dividend 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Techne Corp. (TECH) Release: Bio-Techne To Host Conference Call On October 28, 2014 To Announce First Quarter Financial Results 10/21/2014
HEALTHSOUTH Declares Dividend On Common Stock And Dividend On 6.5% Series A Convertible Perpetual Preferred Stock 10/21/2014
Metabolix, Inc. To Conduct Webcast Of Its Third Quarter Fiscal Year 2014 Earnings Call 10/21/2014
Fluidigm Corporation To Announce Q3 2014 Financial Results And Host Conference Call For Investors 10/21/2014
Nine-Month Figures For 2014: Sartorius Grows In Order Intake, Sales Revenue And Earnings 10/21/2014
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Warrants 10/21/2014
Tianyin Pharmaceutical Co, Inc. Received Notices Of Non-Compliance From NYSE MKT 10/21/2014
DBV Technologies Announces Proposed Global Offering 10/20/2014
Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC 10/20/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC 10/20/2014
Acasti Pharma Announces Grant Of Stock Options 10/20/2014
Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist 10/20/2014
AbbVie (ABBV) Still A Buy Despite Shire Fallout, Says Analyst 10/17/2014
TiGenix Publishes Transparency Notification Pursuant To Article 14 Of The Law Of May 2, 2007 10/17/2014
TetraPhase Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock 10/17/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/17/2014
Celator Pharmaceuticals, Inc. Announces Public Offering Of Common Stock And Warrants To Purchase Common Stock 10/17/2014
VG Life Sciences, Inc. (VGLS) Announces Upgrading To OTCQB Marketplace 10/17/2014
Cowen and Company: Best Buys, Favorable Biotech Outlook Remain 10/17/2014
Esperion Therapeutics, Inc. (ESPR) Prices Public Offering Of Common Stock 10/16/2014
Nasdaq Welcomes Atara Biotherapeutics (ATRA) To The Nasdaq Stock Market 10/16/2014
TetraPhase Pharmaceuticals Announces Proposed Public Offering Of Common Stock 10/16/2014
Anatara Lifesciences Successfully Lists On The ASX 10/16/2014
Roche (RHHBY) Delivers Solid Sales Growth For The First Nine Months Of 2014 10/16/2014
Medivir AB (MVRBF): Optimization Of Capital Structure 10/16/2014
Roche (RHHBY) Lucentis, Regeneron (REGN) Eylea Continue To Battle It Out In Eye Market 10/16/2014
Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants 10/16/2014
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 10/16/2014
Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000 10/16/2014
Ligand Pharmaceuticals Inc. (LGND) To Host Analyst Day On November 18th In New York City 10/16/2014
Agios Pharmaceuticals (AGIO) Smart Buy Ahead Of Cancer Data: Citi 10/16/2014
Nasdaq Welcomes Forward Pharma (FWP) To The Nasdaq Stock Market 10/15/2014
Walking Dead: Biotech "Zombie" Companies And Why They Are Failing 10/15/2014
Selecta Biosciences, Inc. Announces More Than $20 Million In Equity Funding 10/15/2014
ChrysCapital In Talks With Private Equity Firms To Sell 11% In Mankind Pharma 10/15/2014
VG Life Sciences, Inc. (VGLS) Announces SEC Form 10 Review Complete 10/15/2014
Neptune Technologies & Bioressources Inc. Announces Normal Course Issuer Bid 10/15/2014
Tauriga Sciences Inc. (TAUG) Completely Free Of Convertible Debt 10/15/2014
Transcept Pharmaceuticals, Inc. (TSPT) Declares Special Dividend Of $12.79 Million And Additional Contingent Future Amounts In Connection With Its Merger With Paratek Pharmaceuticals, Inc. 10/15/2014
ContraVir Pharmaceuticals Closes $9.0 Million Financing To Advance Lead Shingles Candidate 10/15/2014
Sensient Technologies Corporation Announces Conference Call 10/15/2014
Tianyin Pharmaceutical Co, Inc. Provides Update On Filing Of Form 10-K For Fiscal Year Ended June 30, 2014 10/15/2014
Orexo AB (ORXOF) Appoints Nomination Committee And Publishes Financial Calendar 2014/2015 10/15/2014
Announcement Regarding Submission Of Tender Offer For Shares In Ambit Biosciences 10/15/2014
UBS: Gilead Sciences, Inc. (GILD) Remains Solid Buy Despite Irish Tax Changes, Price War 10/15/2014
Merck & Co. (MRK) Announces Pricing Of Tender Offers For Eight Series Of Notes 10/15/2014
Esperion Therapeutics, Inc. (ESPR) Announces Proposed Public Offering Of Common Stock 10/15/2014
Preliminary Q3 2014 Report: CytoSorbents, Inc. Achieves Its First Quarter of Approximately $1M in CytoSorb® Sales and Provides Up-listing Update 10/14/2014
Easton Pharmaceuticals (OP: EAPH) Secures Financing Commitment Towards Closing Of Its Option On Canadian Medical Marijuana Facility And Business 10/14/2014
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 10/14/2014
Immunodiagnostic Systems Holdings plc Trading Update 10/14/2014
Sunshine Biopharma, Inc. Retains Renmark Financial Communications To Provide Investor Relations 10/14/2014
Nextech Venture Invest Announces First Closing Of Oncology Fund IV 10/14/2014
New Irish Tax Rules Won’t Faze Biotech: Analyst 10/14/2014
Cytori Therapeutics, Inc. (CYTX) Announces Closing Of Financing 10/13/2014
Repligen Corporation (RGEN) To Host Investor & Analyst Event On October 16 10/13/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program 10/13/2014
Chimerix, Inc. (CMRX) To Webcast R&D Update On October 15th 10/13/2014
Bristol-Myers Squibb Company (BMY) To Hold Investor Teleconference To Discuss CMSTO Highlights 10/13/2014
Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc. (GILD) 10/13/2014
Spinal Atrophy Drug From Isis Pharmaceuticals, Inc. (ISIS) Showing Promise, Says UBS 10/13/2014
PRAC Decision On Leukemia Drug Good News For Ariad Pharmaceuticals, Inc. (ARIA), Says Analyst 10/10/2014
BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech 10/10/2014
Synthetic Biologics, Inc. (SYN) To Raise $20.7 Million In Registered Direct Offering 10/10/2014
PTC Therapeutics, Inc. (PTCT) Announces Pricing Of Public Offering Of Common Stock 10/10/2014
DiaGenic ASA: Ex Right To Receive Subscription Rights In The Rights Issue Today, 10 October 2014 10/10/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Pricing Of Offering Of $75 Million Of 2.00% Convertible Senior Notes Due 2021 10/10/2014
MabVax Therapeutics, Inc. Announces Stock Ticker Symbol Change To MBVX 10/10/2014
CPhI Panel Warns ‘Commitment Dilution’ Hindering Drug Development And Price Pressure Compromising Safety 10/9/2014
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi 10/9/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 10/9/2014
Cross-Over Investing All The Rage, Say VCs On Panel 10/9/2014
Skyepharma PLC (SKYEF) – Interim Management Statement 10/9/2014
PTC Therapeutics, Inc. (PTCT) Announces Proposed Public Offering Of Common Stock 10/9/2014
Arrowhead Research Corporation (ARWR) Issues Open Letter To Shareholders 10/9/2014
AVANIR Pharmaceuticals (AVNR) To Host Investor Briefing On October 15, 2014 10/9/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Proposed Offering Of $70 Million Of Convertible Senior Notes Due 2021 10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO 10/8/2014
Cytori Therapeutics, Inc. (CYTX) Raises $13.5 Million In Registered Direct Offering 10/8/2014
Sand Hill Angels Continues To Invest In Mobile And The Cloud Participating In Perkville's $2.4 Million Dollar Series A 10/8/2014
Medivir AB (MVRBF) Capital Markets Meeting on 16 October 2014 10/7/2014
Radius (RDUS) Announces Closing Of Public Offering Of Common Stock And Partial Exercise Of Underwriters' Option To Purchase Additional Shares 10/7/2014
Therapix Biosciences ADRs Begin Trading On The OTCQB® 10/7/2014
Asterias Biotherapeutics To List Its Series A Common Stock On NYSE MKT 10/7/2014
Cellular Biomedicine Group (CBMG) Calls For General Annual Stockholder Meeting On November 07, 2014 10/7/2014
BioDelivery Sciences International (BDSI) To Provide BUNAVAIL Launch Update 10/7/2014
Avidity NanoMedicines Expands Investor Syndicate 10/7/2014
Oncologix Tech, Inc.  (OTCBB: OCLG) Continues Debt Reduction Strategy; Strengthens Company's Stock Position And Shareholder Value 10/7/2014
Exostar Obtains $5 Million Investment For Their Growing Healthcare Business 10/7/2014
Retrophin (RTRX) Booted CEO For Multiple Stock Violations: Report 10/6/2014
Agios Pharmaceuticals (AGIO) To Webcast R&D Day On October 15, 2014 10/6/2014
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 10/6/2014
LabStyle Innovations Implements 1-For-5 Reverse Stock Split 10/6/2014
Cord Blood America, Inc. Announces Divestiture Of Biocordcell Argentina, S.A. 10/6/2014
Medtech Startup Embo Medical Secures €3 Million Investment 10/6/2014
iBio, Inc. (IBIO) Reports On Filing Of 2014 Annual Report 10/6/2014
Vitrolife (VITR.ST): Invitation To Capital Markets Day On November 6 10/6/2014
Merck & Co. (MRK) Announces Tender Offers For Eight Series Of Notes 10/6/2014
Merck & Co. (MRK) Announces Proposed Public Debt Offering 10/6/2014
Retrophin (RTRX) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10/3/2014
Biotech Boom On Third Coast Proves Everything's Bigger In Texas 10/3/2014
Piper Jaffray: Companies Should Start Stockpiling Now For Ebola 10/3/2014
Venture Capital Pours Into Biotech For Biggest Quarter Since 2012: Report 10/3/2014
Salix Pharmaceuticals, Ltd. (SLXP) To Ring The Nasdaq Stock Market Closing Bell 10/3/2014
Portola Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock 10/3/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Pricing Of Follow-On Offering 10/3/2014
Mylan Inc. (MYL) Increases Third Quarter And Full Year 2014 Adjusted Diluted EPS Guidance Range 10/3/2014
Sevion Therapeutics Announces New Ticker Symbol “SVON” 10/3/2014
Opexa Therapeutics (OPXA) Announces Analyst And Investor Event 10/3/2014
Antibe Therapeutics Inc. Reports on Results of AGM Voting 10/3/2014
Chimerix, Inc. (CMRX)’s Brincidofovir An Ebola Standout For Traders, Says Analyst 10/2/2014
ISS Urges Allergan Inc. (AGN) To Give Investors Vote, Questions Credibility 10/2/2014
Radius (RDUS) Announces Pricing Of Public Offering 10/2/2014
Veracyte, Inc. (VCYT) To Host Investor Day On October 9, 2014 10/2/2014
Radius (RDUS) Announces Proposed Public Offering 10/2/2014
JSS Medical Research Announces Equity Investment By Capital Croissance PME (CCPME) 10/2/2014
Portola Pharmaceuticals, Inc. Announces Proposed Offering Of Common Stock 10/2/2014
Resverlogix Corporation (RVX.TO) Corporate Update Conference Call & Webcast Announcement 10/2/2014
Momenta Pharmaceuticals, Inc. (MNTA) To Host 2014 R&D Day 10/2/2014
Pfenex Inc. (PFNX) Added To Both Russell Microcap® Index And Russell Global Indexes 10/2/2014
Lightlake Therapeutics Inc. (LLTP) Announces Closing Of Investments In Two Products 10/2/2014
Aptose Biosciences Announces Reverse Stock Split 10/2/2014
Perrigo Company (PRGO) Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/2/2014
Ardelyx Inc. (ARDX) Looks Good After Tenanpanor Results: Citi Analysts 10/1/2014
H&Q Life Sciences Investors Pays Stock Distribution 10/1/2014
Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp) (LH)’s Zero Coupon Convertible Subordinated Notes Due 2021 10/1/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Launch Of Proposed Follow-On Offering 10/1/2014
Otonomy, Inc. (OTIC) Added To Russell 2000® Index 10/1/2014
Assembly Biosciences Announces $15.75 Million Registered Direct Offering 10/1/2014
Perrigo Company (PRGO) Announces Extension Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 10/1/2014
Aerie Pharmaceuticals, Inc. (AERI) Announces Closing Of $125 Million Convertible Notes Financing 10/1/2014
BrainStorm Cell Therapeutics Inc. Completes Uplisting To The NASDAQ Capital Market 10/1/2014
Abstracts For Merck & Co. (MRK), Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Look Promising, Says ISI 10/1/2014
If Allergan Inc. (AGN) Survives Valeant (VRX), AbbVie (ABBV), Shire or Actavis (ACT)/Forest May Be Suitors 9/30/2014
Portage Announces Conversion Of Its Debt Into Equity 9/30/2014
Catabasis Pharmaceuticals, Inc. Management To Present At October Investor Conferences 9/30/2014
TNI BioTech's CEO Issues Letter To Shareholders Discussing Cytocom Dividend 9/30/2014
Allergy Therapeutics plc Release: Amendment Of 2012 Loan Note Term 9/30/2014
Pfizer (PFE) Will Wait Out Midterm Elections For Favorable Inversion Laws: Analyst 9/30/2014
Alimera Sciences (ALIM) Provides Details On FDA Approval Of Iluvien® As The First Long-Term Treatment For Diabetic Macular Edema 9/29/2014
BioTie Therapies Corp.'s Financial Information In 2015 9/29/2014
Tesaro, Inc. (TSRO) Announces Closing Of $201.25 Million Public Offering Of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise Of The Underwriters' Option To Purchase Additional Notes 9/29/2014
"Cascade” Of Biotech M&A Will Transform Specialty Pharma: Cowen 9/29/2014
Analysts Say Valeant Pharmaceuticals International (VRX)/Allergan Inc. (AGN) Deal Could Lead To Buying Spree 9/29/2014
Roche (RHHBY) Purchases Shares In Tender Offer For InterMune, Inc. (ITMN) 9/29/2014
Lpath, Inc. (LPTN) Announces Closing of $12.5 Million Registered Direct Offering 9/29/2014
Agrisoma Biosciences Inc. Announces Closing Of Series A Round 9/29/2014
RXi Pharmaceuticals (RXII) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/29/2014
AVANIR Pharmaceuticals (AVNR) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/29/2014
NeoStem, Inc. Secures Debt Facility 9/29/2014
GW Pharmaceuticals Research And Development Day Details 9/29/2014
Asterias Biotherapeutics Announces Distribution Date Of Biotime Warrants And Conversion Date Of Series B Common Stock Into Series A Common Stock 9/29/2014
Gilead Sciences, Inc. (GILD)'s Harvoni Will Fast Track: Analyst 9/26/2014
AVEO Oncology (AVEO) Terminates Cambridge Lease Agreement To Save $110 Million 9/26/2014
Pentwater Capital Management Issues Letter To Board Of Directors Of Allergan Inc. (AGN) 9/26/2014
China Cord Blood Corporation To Hold Annual General Meeting In Hong Kong On December 11, 2014 9/26/2014
Cellceutix (CTIX) Provides Update To Shareholders 9/26/2014
Analyst: Novartis AG (NVS), Celgene (CELG) Might Go Toe-to-Toe Over Psoriasis Drugs 9/26/2014
Amarantus BioSciences, Inc. Shareholders Approve All Matters Voted Upon At Annual Shareholders Meeting 9/26/2014
Galena Biopharma  (GALE) Announces Release Of Special Committee Report And Hosting Of A Conference Call To Provide A Corporate Update 9/26/2014
Karyopharm Therapeutics (KPTI) To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014 9/26/2014
HEALTHSOUTH Announces Date Of 2014 Third Quarter Earnings Conference Call 9/26/2014
Allergan Inc. (AGN) Issues Statement Regarding Recent Valeant Pharmaceuticals International (VRX) Correspondence 9/25/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/25/2014
Regeneus (RGS.AX) (ASX:RGS) Receives R&D Tax Incentive Refund Of $3.7 Million 9/25/2014
Antisense Therapeutics Limited (ANP.AX) Release: Placement And Share Purchase Plan 9/25/2014
TNI BioTech Announces Its Stock Is Now DTC DWAC/FAST Eligible 9/24/2014
AVANIR Pharmaceuticals (AVNR) Announces Pricing Of Public Offering Of Common Stock 9/24/2014
Expiration of the U.S. Tender Offer For CFR Pharmaceuticals 9/24/2014
Valeant Pharmaceuticals International (VRX) Provides Update On Third Quarter Results And Sends Letter To Allergan Inc. (AGN) CEO And Lead Independent Director 9/24/2014
Clinigen Release: Underlying EBITDA Up 19.8% And EPS Up 22% 9/24/2014
The Medicines Company (MDCO) To Webcast Infectious Disease Care Investor & Analyst Day On September 24 9/24/2014
TAP Biosystems Release: New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors 9/24/2014



//-->